openPR Logo
Press release

Insight into the Latest Developments in Oligonucleotide Delivery Systems

10-29-2019 11:37 AM CET | Health & Medicine

Press release from: SMi Group

RNA Therapeutics Conference & Oligonucleotide Delivery Systems Focus Day

RNA Therapeutics Conference & Oligonucleotide Delivery Systems Focus Day

SMi Group are proud to present the new RNA Therapeutics Focus Day - Oligonucleotide Delivery Systems. The Focus Day will be held on the 18th of February 2020 and will present sessions that showcase a myriad of delivery approaches such as: optimising nanoparticle delivery to treat cancer and fibrosis; a review of common NA-LNP tolerability concerns to improve safety of nucleic acid therapeutics and the utility of light-triggered liposomes for retinal delivery.

In addition to this, delegates will have the opportunity to network with Global Product Managers, Heads of Drug Development, Senior Directors, Heads of Research and Development and many more.

As the only RNA therapeutics conference to dedicate a focus day to exploring developments and innovations in oligonucleotide delivery systems, the Oligonucleotide Delivery Systems Focus Day is a key diary date for those in the industry.

An early bird savings of £400 is available to those who register by 31st October. Register now at: www.therapeutics-rna.com/openPR3

Focus Day Highlights:
Optimising Nanoparticle mediated delivery of siRNAs to treat cancer and fibrosis
• Presenting a polypeptide nanoparticle mediated delivery system for siRNA therapeutics to treat cancer and fibrosis
• The benefits of the ability to deliver multiple siRNAs within the tumour microenvironment
• Leveraging this capability to improve outcomes with Immune Checkpoint inhibitors
• Improved GMP manufacturing approaches using microfluidics for clinical development
David Evans, CSO, Sirnaomics

Addressing the challenge of chronic dosing via traditional LNPbased delivery for mRNA therapeutics
• Clinical appeal of lipid nanoparticle delivery systems and other competing modes of delivery
• Challenges in production and screening of LNP candidates for effective translation to biotherapeutics
• Complications of chronic dosing and acceptable tolerability profiles
• Showcasing the development of a tolerable subcutaneous administration of mRNA via functionalised LNPs
Shalini Andersson, Chief Scientist New Therapeutic Modalities, AstraZeneca

Exploring the development and progress of BioNTech mRNA therapeutic delivery platforms
• BioNtech’s approach to mRNA therapeutic delivery
• The mRNA oncology delivery platform
• Targeting the immune system via modified mRNA-encoding antigens
• Progress in protein-based replacement therapies to treat rare disease
• Current opportunities and challenges
Heinrich Haas, VP RNA Formulation & Drug Delivery, BioNTech

Download the brochure and full programme from the event website at www.therapeutics-rna.com/openPR3

RNA Therapeutics
Focus Day: 18th February 2020
Conference: 19th – 20th February 2020
Copthorne Tara Hotel, London, UK

Proudly sponsored by:
ChemGenes | Thermo Fisher Scientific

--- ENDS –

Contact Information:

For media enquiries contact Alia Malick on +44 (0)20 7827 6168

For all delegate enquiries, contact Hakam Panum on +44 (0)20 7827 6128

SMi Group
India House
45 Curlew Street
London
SE1 2ND

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insight into the Latest Developments in Oligonucleotide Delivery Systems here

News-ID: 1857931 • Views: 137

More Releases from SMi Group

Pharma Microbiology UK Conference to discuss Environmental Monitoring
SMi Reports: The Pharmaceutical Microbiology UK conference, taking place on 20 and 21 January 2020 in London, will include a variety of innovative presentations from the environmental monitoring field. With the slowdown in world economic growth, the Pharmaceutical & Biotechnology Environmental Monitoring industry has suffered a certain impact. However, it has still maintained a relatively optimistic growth over the past four years, as the market size maintained an annual growth rate
Exclusive platform updates on the ASCOD, AJAX, Challenger 2, Warrior IFV, PATRIA …
SMi Reports: Senior experts to present exclusive communication and systems updates at the Future Armoured Vehicles Situational Conference in London, next April SMi Group’s 5th Annual Future Armoured Vehicles Situational Awareness will commence on the 1st and 2nd April 2020, in London. The conference will delve deeper into the role of industry, inviting technical leads, platform managers and programme directors to share their insights on the latest systems and sub-systems, providing
Registration Opens for Future Armoured Vehicles Situational Awareness 2020 in Lo …
SMi reports: The agenda has been released for the upcoming Future Armoured Vehicles Situational Awareness Conference, taking place in London in April 2020. In an increasingly complex and congested digital battlespace, the need to provide near real-time information on the whereabouts of an adversary’s location and intent, using enhanced situational awareness capabilities, is vital in aiding armoured units to respond quickly to incoming threats. It is therefore imperative for defence forces
Registration opens for Smart Water Systems Conference 2020
SMi Reports: Registration now available for SMi’s 9th Annual Smart Water Systems, in London. SMi Group is proud to announce the 9th Annual Smart Water Systems Conference which will take place on 20th – 21st April 2020, in London, UK. The two-day event will offer updates on current projects through case studies from water utility companies such as Anglian Water, De Watergroep, SES Water, DWR Cymru Welsh Water, Thames Water and

All 5 Releases


More Releases for RNA

RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
Automated DNA/RNA Isolation System Market Overview Till 2018-2023
Future Market Reports on Global Automated DNA/RNA Isolation System 2018 Research Report presents a professional and complete analysis of on the current Industry situation. The Global report includes Automated DNA/RNA Isolation System Revenue, market Share, industry volume, Trends, Growth aspects. It analyses the important factors of the based on present industry situations, demands, business strategies utilized by Automated DNA/RNA Isolation System market players and the future prospects from various angles
RNA Sequencing: Technologies and Analyses of Global Market Trends
"The Latest Research Report RNA Sequencing: Technologies and Global Markets provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" The global RNA-Sequencing market reached nearly $1.1 billion in 2015, and should reach $1.2 billion in 2016 and $2.1 billion in 2020, registering a compound annual growth rate (CAGR) of 14.9%. The tools and reagents segment should reach over $1.0 billion in 2020 from $566.8
Topics Presented this February 2018 at RNA Therapeutics
SMi’s RNA Therapeutics will be bringing a global presence from MHRA, The RNA Institute, MiNA Therapeutics, AstraZeneca R&D, GSK, Sanofi, CureVac and more. With an agenda full of exciting and new approaches, examine the latest developments in delivery systems for RNA Therapeutics, including Exosomes, Nanocomplexes and Platform Delivery Approaches and patenting RNA Therapeutics. www.therapeutics-rna.com/opr Spotlight: Want to learn about exploiting exosomes for therapeutic use in patients with cystic fibrosis? Have questions answered during
RNA Analysis Market worth 3.62 billion USD by 2021
RNA Analysis Market size was around USD 1.89 billion in 2016. It is expected to grow at a CAGR of 13.9% to reach USD 3.62 billion by 2021. The market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines. However, lack of skilled professionals in the transcriptomics field and lack
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led